Literature DB >> 12791516

Mediation of vascular relaxation in epineurial arterioles of the sciatic nerve: effect of diabetes in type 1 and type 2 diabetic rat models.

Lawrence J Coppey1, Jill S Gellett, Mark A Yorek.   

Abstract

Previously, the authors have reported that acetylcholine-induced vascular relaxation in epineurial arterioles of the sciatic nerve is mediated by nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF). Furthermore, they have demonstrated that acetylcholine-induced vasodilation in these vessels is impaired in streptozotocin-induced (type 1) and ZDF obese (type 2) diabetic rats. In the present study, the authors sought to determine the effect of diabetes on NO- and EDHF-mediated vasodilation in epineurial arterioles. In epineurial arterioles from nondiabetic Sprague-Dawley rats, NO and EDHF are equivalent in regard to their contribution to acetylcholine-induced vascular relaxation. In contrast, NO accounts for a greater portion of acetylcholine-induced vascular relaxation in normal glycemic ZDF lean rats. Following 4 weeks of hyperglycemia, the EDHF component of acetylcholine-induced vascular relaxation was totally inhibited in both streptozotocin-induced and ZDF obese diabetic rats. Vasodilation mediated by NO was still active in epineurial arterioles from both type 1 and type 2 diabetic rat models. These data suggest that diabetes causes an impairment in EDHF-mediated vascular relaxation and that interventions directed at improving EDHF production or bioactivity may improve vascular function in epineurial arterioles in diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791516     DOI: 10.1080/10623320303366

Source DB:  PubMed          Journal:  Endothelium        ISSN: 1026-793X


  13 in total

1.  Endothelium-derived hyperpolarizing factor and diabetes.

Authors:  Xue Gao; Luis A Martinez-Lemus; Cuihua Zhang
Journal:  World J Cardiol       Date:  2011-01-26

2.  Impaired small-conductance Ca2+-activated K+ channel-dependent EDHF responses in Type II diabetic ZDF rats.

Authors:  Matthew P Burnham; Ian T Johnson; Arthur H Weston
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

Review 3.  Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS.

Authors:  Selim Cellek; Norman E Cameron; Mary A Cotter; Christopher H Fry; Dapo Ilo
Journal:  Nat Rev Urol       Date:  2014-03-11       Impact factor: 14.432

4.  Impaired Corneal Sensation and Nerve Loss in a Type 2 Rat Model of Chronic Diabetes Is Reversible With Combination Therapy of Menhaden Oil, α-Lipoic Acid, and Enalapril.

Authors:  Eric P Davidson; Lawrence J Coppey; Hanna Shevalye; Alexander Obrosov; Randy H Kardon; Mark A Yorek
Journal:  Cornea       Date:  2017-06       Impact factor: 2.651

5.  Role of endothelium-dependent hyperpolarisation and prostacyclin in diabetes.

Authors:  Siti Safiah Mokhtar; Aida Hanum Ghulam Rasool
Journal:  Malays J Med Sci       Date:  2015 Mar-Apr

6.  Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction.

Authors:  C L Oltman; E P Davidson; L J Coppey; T L Kleinschmidt; M A Yorek
Journal:  Diabetes Obes Metab       Date:  2008-06-16       Impact factor: 6.577

Review 7.  Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.

Authors:  Mark A Yorek
Journal:  Rev Diabet Stud       Date:  2015-08-10

8.  Reduced EDHF responses and connexin activity in mesenteric arteries from the insulin-resistant obese Zucker rat.

Authors:  E J Young; M A Hill; W B Wiehler; C R Triggle; J J Reid
Journal:  Diabetologia       Date:  2008-03-07       Impact factor: 10.122

9.  Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: a new animal model for type 2 diabetes.

Authors:  Eric P Davidson; Lawrence J Coppey; Amey Holmes; Sergey Lupachyk; Brian L Dake; Christine L Oltman; Richard G Peterson; Mark A Yorek
Journal:  J Diabetes Res       Date:  2014-10-13       Impact factor: 4.011

10.  Vascular and neural dysfunctions in obese Zucker rats: effect of AVE7688.

Authors:  Eric P Davidson; Lawrence J Coppey; Travis L Kleinschmidt; Christine L Oltman; Mark A Yorek
Journal:  Exp Diabetes Res       Date:  2009-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.